Cardiogen

Cardiogen is a synthetic peptide bioregulator developed in Russia, belonging to the class of Khavinson peptides. These compounds are designed to interact with specific genetic sequences, influencing protein synthesis and cellular function. Cardiogen is specifically formulated to support the cardiovascular system. It is synthesized to mimic a portion of a natural peptide found in heart tissue, aiming to restore and maintain the functional integrity of cardiomyocytes, the cells of the heart muscle. Its short amino acid sequence is believed to allow it to act as a signaling molecule, modulating gene expression associated with cardiovascular health and potentially contributing to longevity by supporting the long-term health of the heart. The concept behind peptide bioregulators like Cardiogen is rooted in the epigenetic theory of aging, which suggests that changes in gene expression, rather than just DNA mutations, play a significant role in the aging process. By interacting with DNA, these peptides are hypothesized to optimize gene expression, thereby improving cellular function and extending lifespan. Cardiogen is not a drug in the traditional sense, but rather a functional compound intended to support physiological processes. It is typically available as an oral supplement. Information regarding its use and efficacy largely stems from research conducted in Eastern Europe, particularly Russia. (Source: PubChem, DrugBank)